Benoquin Cream
Developed to mitigate skin pigmentation irregularities to support uniform skin tone and target remaining follicular melanin.
- Category
- Skin Care
- Active ingredient
- Monobenzone
- Route
- Cutaneous use
- Form
- Cream
- Strengths
- 20gr
Prescription and consultation requirements for Benoquin Cream vary by destination and are determined by the fulfilment partner.
Benoquin Cream details
- Condition
- Vitiligo
- Alternative names
- monobenzone
- Therapeutic class
- Depigmenting Agent
- Pharmacological class
- Melanin Synthesis Inhibitor
- Contraindications
- normal skin depigmentation intent; hypersensitivity to monobenzone
- Minor side effects
- erythema; skin peeling
- Moderate side effects
- skin dryness; pruritus; transient hyperpigmentation
- Serious side effects
- severe skin irritation, requires immediate medical attention
- Dosage forms
- Cream
- Administration route
- Cutaneous use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Valeant Pharmaceuticals
- Onset Time
- 1–4 months
- Storage instructions
- Store below 25°C.
- Age restrictions
- Approved for adults.
Patient summary
developed to mitigate skin pigmentation irregularities to support uniform skin tone and target remaining follicular melanin.
Mechanism of action
Increases the excretion of melanin from melanocytes, inducing permanent depigmentation in normal areas to match white patches.
Pregnancy and breastfeeding
TGA Category C: Safety not verified in human pregnancies. Breastfeeding: Consult a doctor.